Osaic Holdings’s Rani Therapeutics RANI Stock Holding History

Osaic Holdings’s Portfolio RANI Stock Details RANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.4K	Buy	4,287 +500	+13%	+$399	﹤0.01%	7142
2026 Q2	$2.88K	Buy	+3,787	New	+$3.36K	﹤0.01%	7155
2026 Q1	–	Sell	-1,000	Closed	-$1.35K	–	8020
2025 Q4	$1.35K	Hold	1,000	–	–	﹤0.01%	7192
2025 Q3	$490	Sell	1,000 -5,668	-85%	-$2.95K	﹤0.01%	7552
2025 Q2	$3.4K	Hold	6,668	–	–	﹤0.01%	6742
2025 Q1	$8.4K	Buy	6,668 +5,168	+345%	+$7.65K	﹤0.01%	5884
2024 Q4	$2.06K	Buy	+1,500	New	+$3.15K	﹤0.01%	6590
2022 Q3	–	Sell	-19,012	Closed	-$196K	–	7461
2022 Q2	$196K	Sell	19,012 -331	-2%	-$3.8K	﹤0.01%	3818
2022 Q1	$261K	Sell	19,343 -1,729	-8%	-$28.7K	﹤0.01%	3797
2021 Q4	$344K	Buy	+21,072	New	+$479K	﹤0.01%	3426

Other funds holding RANI

Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Kestra Private Wealth Services Austin, Texas $9.37B AUM 22.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $24.3B AUM 19.37% 1-Year Est. Return

Well Done LLC Holland, Michigan $732M AUM 14.62% 1-Year Est. Return

MOTCO San Antonio, Texas $1.22B AUM 20.31% 1-Year Est. Return

Osaic Holdings's RANI Position: Q3 2026 in Review

Osaic Holdings increased its Rani Therapeutics (RANI) stake by 13% in Q3 2026, buying an estimated $399 and bringing the position to 4,287 shares worth $3.4K. The position accounts for ﹤0.01% of the portfolio, ranked #7142.

Osaic Holdings first reported a position in RANI in Q4 2021 and has held it in 10 quarters since. The position peaked at $344K in Q4 2021. 33 funds tracked by Wall St. Rank hold RANI as of Q3 2026.

Osaic Holdings held 4,287 shares of Rani Therapeutics worth $3.4K as of Q3 2026.
Osaic Holdings bought 500 Rani Therapeutics shares in Q3 2026, an estimated $399.
Rani Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #7142 holding.
Osaic Holdings first reported a position in Rani Therapeutics in Q4 2021 and has held it in 10 quarters since.
Osaic Holdings's Rani Therapeutics position peaked at $344K in Q4 2021.
33 funds tracked by Wall St. Rank held Rani Therapeutics as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.